Our Coronavirus Efforts
Takeda and other world-leading plasma companies have come together to focus on developing a hyperimmune globulin in the global fight against COVID-19. If you live in the United States and have recovered from COVID-19, your plasma may have the power to help others through a potential therapy.
Visit the CoVIg-19 Plasma Alliance website to learn more.
Takeda R&D's COVID-19 Efforts (YouTube) highlights our activities.
|April 6||Global Plasma Leaders Collaborate to Accelerate Development of Potential COVID-19 Hyperimmune Therapy|
|March 25||Takeda Research & Development and COVID-19|
|March 23||Coronavirus and Product Supply|
|March 19||Coronavirus: Adjusting Our Business Approach While Serving Our Patients|
|March 6||Rajeev Venkayya, President, Global Vaccine Business Unit on the latest on the Coronavirus and Takeda|
|March 4||Takeda Initiates Development of a Plasma-Derived Therapy for COVID-19|